The Journal of Urology
Volume 180, Issue 1 , Pages 31-37 , July 2008

The Causal Role of Cigarette Smoking in Bladder Cancer Initiation and Progression, and the Role of Urologists in Smoking Cessation

  • Seth A. Strope
    • ,
  • James E. Montie

      Affiliations

    • Corresponding Author InformationCorrespondence: Department of Urology, University of Michigan Health System, 1500 East Medical Center Dr., TC 3875, Ann Arbor, Michigan 48109-0330 (telephone: 734-764-0251; FAX: 734-936-8037).

Received 7 November 2007

References 

  1. Windish DM, Huot SJ, Green ML. Medicine residents' understanding of the biostatistics and results in the medical literature. JAMA. 2007;298:1010
  2. Nieder AM, John S, Messina CR, Granek IA, Adler HL. Are patients aware of the association between smoking and bladder cancer?. J Urol. 2006;176:2405
  3. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43
  4. Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics. 2003;21:1315
  5. Messing EM. Urothelial tumors of the urinary tract. In:  Walsh PC,  Retik AB,  Vaughan ED,  Wein AJ editor. Campbell's Urology. 8th ed.. Philadelphia: WB Saunders Co; 2002;p. 2732–2784vol 4
  6. Cohen SM, Johansson SL. Epidemiology and etiology of bladder cancer. Urol Clin North Am. 1992;19:421
  7. Walter SD. A generalization of a matrix occupancy problem. Biometrics. 1976;32:471
  8. Greenland S, Rothman KJ. Measures of effect and measures of association. In:  Rothman KJ,  Greenland S editor. Modern Epidemiology. 2nd ed.. Philadelphia: Lippincott Williams&Wilkins; 1998;p. 47–64
  9. Rothman KJ. Epidemiology: An Introduction. In: New York: Oxford University Press; 2002;p. 53–55
  10. Howe GR, Burch JD, Miller AB, Cook GM, Esteve J, Morrison B, et al. Tobacco use, occupation, coffee, various nutrients, and bladder cancer. J Natl Cancer Inst. 1980;64:701
  11. Hartge P, Silverman D, Hoover R, Schairer C, Altman R, Austin D, et al. Changing cigarette habits and bladder cancer risk: a case-control study. J Natl Cancer Inst. 1987;78:1119
  12. Zeegers MP, Goldbohm RA, van denBrandt PA. A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands). Cancer Causes Control. 2002;13:83
  13. Puente D, Hartge P, Greiser E, Cantor KP, King WD, Gonzalez CA, et al. A pooled analysis of bladder cancer case-control studies evaluating smoking in men and women. Cancer Causes Control. 2006;17:71
  14. Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed.. Philadelphia: Lippincott Williams&Wilkins; 1998;
  15. Castelao JE, Yuan JM, Skipper PL, Tannenbaum SR, Gago-Dominguez M, Crowder JS, et al. Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst. 2001;93:538
  16. Zeegers MP, Tan FE, Dorant E, van Den Brandt PA. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer. 2000;88:630
  17. Health Evidence Network (HEN): Smoking prevalence in adults (%), 1994–1998 and 1999–2001. http://www.euro.who.int/HEN/Syntheses/tobcontrol/20030823_1Accessed March 4, 2008
  18. Brennan P, Bogillot O, Cordier S, Greiser E, Schill W, Vineis P, et al. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer. 2000;86:289
  19. Mendez D, Warner KE, Courant PN. Has smoking cessation ceased? (Expected trends in the prevalence of smoking in the United States). Am J Epidemiol. 1998;148:249
  20. Cigarette smoking among adults—United States, 2004. MMWR Morb Mortal Wkly Rep. 2005;54:1121
  21. Brennan P, Bogillot O, Greiser E, Chang-Claude J, Wahrendorf J, Cordier S, et al. The contribution of cigarette smoking to bladder cancer in women (pooled European data). Cancer Causes Control. 2001;12:411
  22. Bjerregaard BK, Raaschou-Nielsen O, Sorensen M, Frederiksen K, Tjonneland A, Rohrmann S, et al. The effect of occasional smoking on smoking-related cancers in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control. 2006;17:1305
  23. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta: United States Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2006;
  24. Alberg AJ, Kouzis A, Genkinger JM, Gallicchio L, Burke AE, Hoffman SC, et al. A prospective cohort study of bladder cancer risk in relation to active cigarette smoking and household exposure to secondhand cigarette smoke. Am J Epidemiol. 2007;165:660
  25. Jiang X, Yuan JM, Skipper PL, Tannenbaum SR, Yu MC. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County. Cancer Res. 2007;67:7540
  26. Lin J, Spitz MR, Dinney CP, Etzel CJ, Grossman HB, Wu X. Bladder cancer risk as modified by family history and smoking. Cancer. 2006;107:705
  27. Cao W, Cai L, Rao JY, Pantuck A, Lu ML, Dalbagni G, et al. Tobacco smoking, GSTP1 polymorphism, and bladder carcinoma. Cancer. 2005;104:2400
  28. Garcia-Closas M, Malats N, Real FX, Welch R, Kogevinas M, Chatterjee N, et al. Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2006;15:536
  29. Kader AK, Shao L, Dinney CP, Schabath MB, Wang Y, Liu J, et al. Matrix metalloproteinase polymorphisms and bladder cancer risk. Cancer Res. 2006;66:11644
  30. Gormally E, Vineis P, Matullo G, Veglia F, Caboux E, Le Roux E, et al. TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective study. Cancer Res. 2006;66:6871
  31. Sak SC, Barrett JH, Paul AB, Bishop DT, Kiltie AE. Comprehensive analysis of 22 XPC polymorphisms and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2006;15:2537
  32. Garcia-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW, et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet. 2005;366:649
  33. Rockhill B. Theorizing about causes at the individual level while estimating effects at the population level: implications for prevention. Epidemiology. 2005;16:124
  34. Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol. 2004;159:882
  35. Fleshner N, Garland J, Moadel A, Herr H, Ostroff J, Trambert R, et al. Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer. 1999;86:2337
  36. Aveyard P, Adab P, Cheng KK, Wallace DM, Hey K, Murphy MF. Does smoking status influence the prognosis of bladder cancer? (A systematic review). BJU Int. 2002;90:228
  37. Chen CH, Shun CT, Huang KH, Huang CY, Tsai YC, Yu HJ, et al. Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer. BJU Int. 2007;100:281
  38. Ostroff J, Garland J, Moadel A, Fleshner N, Hay J, Cramer L, et al. Cigarette smoking patterns in patients after treatment of bladder cancer. J Cancer Educ. 2000;15:86
  39. Centers for Disease Control and Prevention (CDC). Tobacco use among adults—United States, 2005. MMWR Morb Mortal Wkly Rep. 2006;55:1145
  40. Dresler CM, Leon ME, Straif K, Baan R, Secretan B. Reversal of risk upon quitting smoking. Lancet. 2006;368:348
  41. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE, et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005;142:233
  42. Vogt F, Hall S, Marteau TM. General practitioners' beliefs about effectiveness and intentions to prescribe smoking cessation medications: qualitative and quantitative studies. BMC Public Health. 2006;6:277
  43. Tong EK, Ong MK, Vittinghoff E, Perez-Stable EJ. Nondaily smokers should be asked and advised to quit. Am J Prev Med. 2006;30:23
  44. Thorndike AN, Rigotti NA, Stafford RS, Singer DE. National patterns in the treatment of smokers by physicians. JAMA. 1998;279:604
  45. Dearing J. Disease-centred advice for patients with superficial transitional cell carcinoma of the bladder. Ann R Coll Surg Engl. 2005;87:85
  46. Vogt F, Hall S, Marteau TM. General practitioners' and family physicians' negative beliefs and attitudes towards discussing smoking cessation with patients: a systematic review. Addiction. 2005;100:1423
  47. Ferreira-Borges C. Effectiveness of a brief counseling and behavioral intervention for smoking cessation in pregnant women. Prev Med. 2005;41:295
  48. Kottke TE, Brekke ML, Solberg LI, Hughes JR. A randomized trial to increase smoking intervention by physicians (Doctors Helping Smokers, Round I). JAMA. 1989;261:2101
  49. Bao Y, Duan N, Fox SA. Is some provider advice on smoking cessation better than no advice? (An instrumental variable analysis of the 2001 National Health Interview Survey). Health Serv Res. 2006;41:2114
  50. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2004;CD000146
  51. Hughes J, Stead L, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2004;CD000031
  52. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2005;CD001292
  53. Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2005;CD001007

 Editor's Note: This article is the second of 5 published in this issue for which category 1 CME credits can be earned. Instructions for obtaining credits are given with the questions on pages 418 and 419.

PII: S0022-5347(08)00602-2

doi: 10.1016/j.juro.2008.03.045

The Journal of Urology
Volume 180, Issue 1 , Pages 31-37 , July 2008

Article Tools

* Image Usage & Resolution